US Bancorp’s NRC Health Common Stock NRC Stock Holding History

US Bancorp’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$715K	Buy	33,156 +483	+1%	+$8.97K	﹤0.01%	1370
2026 Q1	$555K	Sell	32,673 -1,845	-5%	-$31.4K	﹤0.01%	1447
2025 Q4	$648K	Sell	34,518 -1,526	-4%	-$23K	﹤0.01%	1400
2025 Q3	$461K	Sell	36,044 -2,526	-7%	-$37.9K	﹤0.01%	1555
2025 Q2	$648K	Buy	38,570 +1,372	+4%	+$18.5K	﹤0.01%	1348
2025 Q1	$476K	Sell	37,198 -1,379	-4%	-$22.1K	﹤0.01%	1501
2024 Q4	$680K	Sell	38,577 -7,355	-16%	-$140K	﹤0.01%	1323
2024 Q3	$1.05M	Buy	45,932 +992	+2%	+$22.4K	﹤0.01%	1110
2024 Q2	$1.03M	Sell	44,940 -2,302	-5%	-$71K	﹤0.01%	1093
2024 Q1	$1.87M	Buy	47,242 +21,750	+85%	+$860K	﹤0.01%	872
2023 Q4	$1.01M	Sell	25,492 -208	-0.8%	-$8.71K	﹤0.01%	1110
2023 Q3	$1.14M	Buy	25,700 +2,158	+9%	+$94.2K	﹤0.01%	996
2023 Q2	$1.02M	Sell	23,542 -6,545	-22%	-$288K	﹤0.01%	1061
2023 Q1	$1.31M	Sell	30,087 -53,600	-64%	-$2.37M	﹤0.01%	962
2022 Q4	$3.12M	Buy	83,687 +9,808	+13%	+$379K	0.01%	666
2022 Q3	$2.94M	Sell	73,879 -1,691	-2%	-$62.6K	0.01%	644
2022 Q2	$2.89M	Buy	75,570 +1,217	+2%	+$44K	0.01%	680
2022 Q1	$2.95M	Buy	74,353 +6,671	+10%	+$261K	﹤0.01%	735
2021 Q4	$2.81M	Sell	67,682 -1,741	-3%	-$75.7K	﹤0.01%	785
2021 Q3	$2.93M	Sell	69,423 -5,000	-7%	-$252K	0.01%	744
2021 Q2	$3.42M	Sell	74,423 -269	-0.4%	-$12.8K	0.01%	692
2021 Q1	$3.5M	Buy	74,692 +11,912	+19%	+$579K	0.01%	649
2020 Q4	$2.68M	Buy	62,780 +65	+0.1%	+$3.34K	0.01%	700
2020 Q3	$3.09M	Hold	62,715	–	–	0.01%	609
2020 Q2	$3.65M	Sell	62,715 -2,946	-4%	-$156K	0.01%	557
2020 Q1	$2.99M	Sell	65,661 -90	-0.1%	-$5.41K	0.01%	562
2019 Q4	$4.34M	Buy	65,751 +1,688	+3%	+$103K	0.01%	551
2019 Q3	$3.7M	Buy	64,063 +3,716	+6%	+$230K	0.01%	587
2019 Q2	$3.48M	Hold	60,347	–	–	0.01%	604
2019 Q1	$2.33M	Hold	60,347	–	–	0.01%	710
2018 Q4	$2.3M	Buy	60,347 +37,284	+162%	+$1.43M	0.01%	682
2018 Q3	$890K	Sell	23,063 -9,500	-29%	-$360K	﹤0.01%	1167
2018 Q2	$1.22M	Buy	32,563 +13,459	+70%	+$469K	﹤0.01%	1011
2018 Q1	$559K	Buy	19,104 +4,059	+27%	+$136K	﹤0.01%	1392
2017 Q4	$561K	Hold	15,045	–	–	﹤0.01%	1374
2017 Q3	$567K	Hold	15,045	–	–	﹤0.01%	1367
2017 Q2	$404K	Buy	15,045 +13,805	+1,113%	+$337K	﹤0.01%	1496
2017 Q1	$24K	Hold	1,240	–	–	﹤0.01%	2782
2016 Q4	$24K	Buy	+1,240	New	+$20.5K	﹤0.01%	2765
2016 Q1	–	Sell	-280	Closed	-$4K	–	3615
2015 Q4	$4K	Hold	280	–	–	﹤0.01%	3292
2015 Q3	$3K	Hold	280	–	–	﹤0.01%	3362
2015 Q2	$4K	Hold	280	–	–	﹤0.01%	3336
2015 Q1	$4K	Buy	+280	New	+$3.96K	﹤0.01%	3337
2014 Q2	–	Sell	-2,625	Closed	-$44K	–	3531
2014 Q1	$44K	Sell	2,625 -1,575	-38%	-$26.4K	﹤0.01%	2534
2013 Q4	$79K	Buy	+4,200	New	+$73.7K	﹤0.01%	2223
2013 Q3	–	Sell	-435	Closed	-$8K	–	3315
2013 Q2	$8K	Buy	+435	New	+$6.95K	﹤0.01%	2904

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

WIC

Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

FMII

Farmers & Merchants Investments Inc Lincoln, Nebraska $4.13B AUM 32.58% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

US Bancorp's NRC Position: Q2 2026 in Review

US Bancorp increased its NRC Health Common Stock (NRC) stake by 1.5% in Q2 2026, buying an estimated $8.97K and bringing the position to 33,156 shares worth $715K. The position accounts for ﹤0.01% of the portfolio, ranked #1370.

US Bancorp first reported a position in NRC in Q2 2013 and has held it in 46 quarters since. The position peaked at $4.34M in Q4 2019. 124 funds tracked by Wall St. Rank hold NRC as of Q2 2026.

US Bancorp held 33,156 shares of NRC Health Common Stock worth $715K as of Q2 2026.
US Bancorp bought 483 NRC Health Common Stock shares in Q2 2026, an estimated $8.97K.
NRC Health Common Stock made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1370 holding.
US Bancorp first reported a position in NRC Health Common Stock in Q2 2013 and has held it in 46 quarters since.
US Bancorp's NRC Health Common Stock position peaked at $4.34M in Q4 2019.
124 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.